The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat

Focal ischemia was induced in the fronto-parietal region of rat brain, by injection of Rose Bengal, followed by light activation. Focal ischemia was accompanied by formation of PGD 2 peaking 60–90 min post irradiation and declining thereafter. Increased Cycloxygenase-2 (COX-2) expression was also ob...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience letters Vol. 303; no. 2; pp. 91 - 94
Main Authors Govoni, Stefano, Masoero, Elisabetta, Favalli, Luigia, Rozza, Annalinda, Scelsi, Roberto, Viappiani, Serena, Buccellati, Carola, Sala, Angelo, Folco, Giancarlo
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 04.05.2001
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Focal ischemia was induced in the fronto-parietal region of rat brain, by injection of Rose Bengal, followed by light activation. Focal ischemia was accompanied by formation of PGD 2 peaking 60–90 min post irradiation and declining thereafter. Increased Cycloxygenase-2 (COX-2) expression was also observed. Control ischemic rats showed distinct morphological alterations with necrosis of neurons, glial cells and blood vessels, surrounded by a halo with pyknotic cells with cytoplasm swelling and vacuolization. Compound SC58236, a selective COX-2 inhibitor, dose-dependently prevented, ischemia-induced eicosanoid formation (area under the curve (AUC) of controls: 3.11±0.87; AUC of 20 mg/kg SC58236: 0.39±0.24), and caused significant reduction of damaged area (30.7 and 18.9% at SC58236 20 and 6.6 mg/kg), suggesting that selective inhibitors of COX-2 are neuroprotective.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0304-3940
1872-7972
DOI:10.1016/S0304-3940(01)01675-5